990 related articles for article (PubMed ID: 17302610)
1. Nature of cell kinetics in psoriatic epidermis.
Doger FK; Dikicioglu E; Ergin F; Unal E; Sendur N; Uslu M
J Cutan Pathol; 2007 Mar; 34(3):257-63. PubMed ID: 17302610
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of cell death and proliferation in psoriatic epidermis.
Kawashima K; Doi H; Ito Y; Shibata MA; Yoshinaka R; Otsuki Y
J Dermatol Sci; 2004 Sep; 35(3):207-14. PubMed ID: 15381242
[TBL] [Abstract][Full Text] [Related]
3. Expression of antiapoptotic protein c-FLIP is upregulated in psoriasis epidermis.
Yang J; Li Y; Liu YQ; Long JW; Tian F; Dong J; Shen GX; Tu YT; Tao J
Eur J Dermatol; 2009; 19(1):29-33. PubMed ID: 19059832
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of survivin and NF-kappaB in psoriasis, an immunohistochemical study.
Abdou AG; Hanout HM
J Cutan Pathol; 2008 May; 35(5):445-51. PubMed ID: 18005174
[TBL] [Abstract][Full Text] [Related]
5. Apoptosis in psoriatic epidermis.
Heenen M; Simonart T
J Cutan Pathol; 2008 Mar; 35(3):346. PubMed ID: 18251754
[No Abstract] [Full Text] [Related]
6. Etanercept does not have an apoptosis-inducing effect on psoriatic keratinocytes.
Tatlican S; Arikok A; Gulbahar O; Eren C; Cevirgen B; Eskioglu F
J Dermatolog Treat; 2010 Sep; 21(5):306-10. PubMed ID: 19878038
[TBL] [Abstract][Full Text] [Related]
7. Effect of vitamin D3 on the increased expression of Bcl-xL in psoriasis.
Fukuya Y; Higaki M; Higaki Y; Kawashima M
Arch Dermatol Res; 2002 Feb; 293(12):620-5. PubMed ID: 11875645
[TBL] [Abstract][Full Text] [Related]
8. The role of heparin-binding EGF-like growth factor and amphiregulin in the epidermal proliferation of psoriasis in cooperation with TNFalpha.
Yoshida A; Kanno H; Watabe D; Akasaka T; Sawai T
Arch Dermatol Res; 2008 Jan; 300(1):37-45. PubMed ID: 17960400
[TBL] [Abstract][Full Text] [Related]
9. Infliximab restores the balance between pro- and anti-apoptotic proteins in regressing psoriatic lesions.
Kokolakis G; Giannikaki E; Stathopoulos E; Avramidis G; Tosca AD; Krüger-Krasagakis S
Br J Dermatol; 2012 Mar; 166(3):491-7. PubMed ID: 21985184
[TBL] [Abstract][Full Text] [Related]
10. Examination of bcl-2 and p53 expressions and apoptotic index by TUNEL method in psoriasis.
Gündüz K; Demireli P; Vatansever S; Inanir I
J Cutan Pathol; 2006 Dec; 33(12):788-92. PubMed ID: 17177938
[TBL] [Abstract][Full Text] [Related]
11. Early effects of tumour necrosis factor alpha blockade on skin and synovial tissue in patients with active psoriasis and psoriatic arthritis.
Goedkoop AY; Kraan MC; Teunissen MB; Picavet DI; de Rie MA; Bos JD; Tak PP
Ann Rheum Dis; 2004 Jul; 63(7):769-73. PubMed ID: 15194570
[TBL] [Abstract][Full Text] [Related]
12. The combination of the Zenon labeling technique and microscopic image analysis to study cell populations in normal and psoriatic epidermis.
van Duijnhoven MW; van de Kerkhof PC; Pasch MC; Muys L; van Erp PE
J Cutan Pathol; 2005 Mar; 32(3):212-9. PubMed ID: 15701083
[TBL] [Abstract][Full Text] [Related]
13. Expression of Bcl-2 family proteins in psoriasis.
Batinac T; Zamolo G; Hadzisejdić I; Zauhar G; Brumini G; Ruzić A; Persić V
Croat Med J; 2007 Jun; 48(3):319-26. PubMed ID: 17589974
[TBL] [Abstract][Full Text] [Related]
14. The effects of calcipotriol and methylprednisolone aseponate on bcl-2, p53 and ki-67 expression in psoriasis.
Adişen E; Gülekon A; Erdem O; Dursun A; Gürer MA
J Eur Acad Dermatol Venereol; 2006 May; 20(5):527-33. PubMed ID: 16684279
[TBL] [Abstract][Full Text] [Related]
15. Plaque psoriasis vs. atopic dermatitis and lichen planus: a comparison for lesional T-cell subsets, epidermal proliferation and differentiation.
Bovenschen HJ; Seyger MM; Van de Kerkhof PC
Br J Dermatol; 2005 Jul; 153(1):72-8. PubMed ID: 16029329
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis, P53 and Bcl-2 expression in response to topical calcipotriol therapy for psoriasis.
El-Domyati M; Barakat M; Abdel-Razek R; El-Din Anbar T
Int J Dermatol; 2007 May; 46(5):468-74. PubMed ID: 17472673
[TBL] [Abstract][Full Text] [Related]
17. Heat shock proteins 60 and 70 expression of cutaneous lichen planus: comparison with normal skin and psoriasis vulgaris.
Bayramgürler D; Ozkara SK; Apaydin R; Erçin C; Bilen N
J Cutan Pathol; 2004 Oct; 31(9):586-94. PubMed ID: 15330989
[TBL] [Abstract][Full Text] [Related]
18. Alteration of the expression of Bcl-2, Bcl-x, Bax, Fas, and Fas ligand in the involved skin of psoriasis vulgaris following topical anthralin therapy.
Yamamoto T; Nishioka K
Skin Pharmacol Appl Skin Physiol; 2003; 16(1):50-8. PubMed ID: 12566829
[TBL] [Abstract][Full Text] [Related]
19. Assessment of epidermal subpopulations and proliferation in healthy skin, symptomless and lesional skin of spreading psoriasis.
Körver JE; van Duijnhoven MW; Pasch MC; van Erp PE; van de Kerkhof PC
Br J Dermatol; 2006 Oct; 155(4):688-94. PubMed ID: 16965416
[TBL] [Abstract][Full Text] [Related]
20. Distribution of dipeptidyl-peptidase IV on keratinocytes in the margin zone of a psoriatic lesion: a comparison with hyperproliferation and aberrant differentiation markers.
van Lingen RG; Poll MK; Seyger MM; de Jong EM; van de Kerkhof PC; van Erp PE
Arch Dermatol Res; 2008 Nov; 300(10):561-7. PubMed ID: 18496701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
